FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN)

CUSIP: 35655L107

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / SPONSORED ADS
Total 13F shares
10,610,967
Share change
-692,511
Total reported value
$36,109,000
Price per share
$3.41
Number of holders
19
Value change
-$7,787,454
Number of buys
14
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 35655L107?
CUSIP 35655L107 identifies FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN) as of Q3 2021

As of 30 Sep 2021, FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,610,967 shares. The largest 10 holders included EVENTIDE ASSET MANAGEMENT, LLC, Novo Holdings A/S, CHI Advisors LLC, Polygon Management Ltd., WELLINGTON MANAGEMENT GROUP LLP, AXA S.A., FRAZIER MANAGEMENT LLC, MARSHALL WACE, LLP, RENAISSANCE TECHNOLOGIES LLC, and TWO SIGMA INVESTMENTS, LP. This page lists 19 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.